These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29173093)

  • 1. Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder.
    Fortinguerra S; Buriani A; Sorrenti V; Lenzi M; Giusti P
    Pharmacogenomics; 2017 Dec; 18(18):1631-1642. PubMed ID: 29173093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbetalipoproteinemia and clomipramine.
    Holmes DT; Long P; Frohlich J
    Am J Psychiatry; 2005 Jul; 162(7):1384-5. PubMed ID: 15994726
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of clomipramine-induced mania on rapid cycling affective disorder].
    Soeda S; Terao T; Nakamura J
    J UOEH; 1999 Dec; 21(4):309-15. PubMed ID: 10629901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Miller AL; Rogers GR; Kennedy MA
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):339-46. PubMed ID: 14604448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic profile and major depressive and/or bipolar disorder treatment: a retrospective, cross-sectional study.
    Tonozzi TR; Braunstein GD; Kammesheidt A; Curran C; Golshan S; Kelsoe J
    Pharmacogenomics; 2018 Oct; 19(15):1169-1179. PubMed ID: 30207201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report.
    Antoniazzi S; Tatulli A; Falvella FS; Cigliobianco M; Paoli RA; Cattaneo D; Cheli S; Bernardi FF; Clementi E; Altamura CA
    J Clin Pharm Ther; 2017 Feb; 42(1):119-121. PubMed ID: 27800629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse of dosulepin to induce mania.
    Lepping P; Menkes DB
    Addiction; 2007 Jul; 102(7):1166-7. PubMed ID: 17567406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine-induced manic switch in adolescent unipolar depression.
    Goyal N; Sinha VK
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
    [No Abstract]   [Full Text] [Related]  

  • 10. Melasma: A rare adverse effect of clomipramine.
    Kar SK
    Indian J Pharmacol; 2016; 48(4):453-454. PubMed ID: 27756961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Switch to mania].
    Ohgake S; Iyo M
    Ryoikibetsu Shokogun Shirizu; 2003; (38):379-80. PubMed ID: 12877007
    [No Abstract]   [Full Text] [Related]  

  • 12. Mirtazapine induced mania in a woman with major depression in the absence of features of bipolarity.
    Basavraj V; Nanjundappa GB; Chandra PS
    Aust N Z J Psychiatry; 2011 Oct; 45(10):901. PubMed ID: 21692606
    [No Abstract]   [Full Text] [Related]  

  • 13. Antidepressive treatment and mood swing patterns in endogenous depression.
    Strian F; Albert W; Klicpera C
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):432-7. PubMed ID: 538088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
    Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
    Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of prolonged seizure after ECT in a patient treated with clomipramine, lithium, L-tryptophan, quetiapine, and thyroxine for major depression.
    Rucker J; Cook M
    J ECT; 2008 Dec; 24(4):272-4. PubMed ID: 18648320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Serretti A; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Pae CU
    Psychiatry Res; 2011 Aug; 189(1):26-32. PubMed ID: 21396719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic aspects of bipolar disorder: An update.
    Budde M; Degner D; Brockmöller J; Schulze TG
    Eur Neuropsychopharmacol; 2017 Jun; 27(6):599-609. PubMed ID: 28342679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomipramine-induced pheochromocytoma crisis: a near fatal complication of a tricyclic antidepressant.
    Korzets A; Floro S; Ori Y; Weizer N; Gruzman C
    J Clin Psychopharmacol; 1997 Oct; 17(5):428-30. PubMed ID: 9315999
    [No Abstract]   [Full Text] [Related]  

  • 19. Aquagenic pruritus induced by clomipramine.
    Mendlowicz MV; Lima JL; Fontenelle LF
    Gen Hosp Psychiatry; 2013; 35(5):577.e3-4. PubMed ID: 23477795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.